Speaking Engagements
2024
“Navigating New and Evolving State Legislation Governing Chemical Contaminants in OTC Products,” American Conference Institute, OTC Drugs Conference, January 23, 2024 (New York, NY).
2023
“FDA Food Safety Modernization Act – Summary and Update,” American Conference Institute, Food Law & Regulation Boot Camp, July 19, 2023 (virtual conference).
“Key Federal and State Agencies,” Food and Drug Law Institute, Introduction to Food Law, September 2022 (recorded for rebroadcast).
2022
“A Guide to Properly Executing a Food Recall,” American Conference Institute, Advanced Summit on Food Law Conference, July 14, 2022 (Chicago, IL).
2021
“Adverse Events Monitoring, Pharmacovigilance, Risk Management, and Recalls,” American Conference Institute, FDA Boot Camp, September 30, 2021 (virtual conference).
“Navigating the Patchwork of State Hemp and CBD Regulation,” Food and Drug Law Institute, Food and Dietary Supplement Safety and Regulation Conference, March 25, 2021 (virtual conference).
“Focus on Recalls – Examining Incidents that Give Rise to Reporting Obligations and Recalls,” American Conference Institute, Advanced Summit on Food Law, May 12, 2021 (virtual conference).
2020
“FDA Labeling Update,” panel discussion at ACI 4th Annual Advanced Summit on Food Law, July 15, 2020 (virtual conference).
“OTC Drug Reform in the CARES Act,” webinar for clients, April 7, 2020.
“The Somewhat Dis-United States: A Patchwork Quilt of Hemp Laws,” presentation at FDLI Food Enforcement and Compliance Conference, March 26, 2020 (virtual conference).
2019
“To CBD or Not to CBD: How to Know If Your CBD Is 2018 Farm Bill Compliant and Key Considerations Before Diving Into the Market,” Retail Industry Leaders Association, Nashville, TN, October 17, 2019.
“Food Recalls,” panel discussion at Food Safety Consortium, Schaumburg, IL, October 1, 2019 “Case Study on Pharmaceutical Advertising and Promotion.”
“Drug and Biologics Advertising and Promotion 101,” speech at American Conference Institute, FDA Boot Camp, Boston, MA, September 19, 2019.
“What Lies Ahead for Hemp and Cannabis-Related Ingredients,” speech at American Conference Institute, Advanced Summit on Food Law, Chicago, IL, April 10, 2019.
“Drugs and Biologics Advertising and Promotion 101,” speech at American Conference Institute, FDA Boot Camp, New York, NY, March 27, 2019.
2018
“Edibles and Infused Products,” panel moderator, at Food & Drug Law Journal Symposium on Federal Regulation of Cannabis, Washington DC, November 2, 2018.
“Policies and Politics – Opportunities and Challenges Facing the FDA,” panel discussion at FDLI Annual Conference, Washington DC, May 3, 2018.
“Best Practices for Managing FDA and USDA Inspections,” panel discussion at American Conference Institute, Food Law Regulation, Litigation, and Compliance, Chicago, IL, April 23, 2018.
“Investigations of Foodborne Illness Outbreaks: The Growing Role of Environmental Monitoring and Whole Genome Sequencing,” panel moderator at FDLI Food Enforcement and Compliance Conference, Washington DC, April 12, 2018.
2017
“What’s the Score with SCORE? FDA’s Guidelines for Food Safety and Enforcement,” panel moderator at FDLI Annual Conference, Washington DC, May 4, 2017.
“Overview of U.S. Food Law and Regulation,” speech at Intro to Food Law and Regulation, Food and Drug Law Institute, Washington, DC, March 2, 2017.
“Class Action Lawsuits Against OTC Drugs,” panel member and presentation at American Conference Institute Program Regulatory and Compliance Forum on Over-the-Counter Drugs, New York, October 28, 2014.Panelist. FDLI Advertising and Promotion for Medical Products Conference. 17 October 2019.
2015
“FDA Update – Inside the Latest FDA Initiatives and How to Re-Adjust Compliance Protocols,” speech at American Conference Institute FDA & USDA Compliance Boot Camp, Chicago, September 28, 2015.
“Adulteration and Your Role in Delivering Value to Consumers: Quality, Safety & Efficacy,” presentation and panel discussion at Dietary Supplement Ingredient Marketplace, Orlando, FL, April 8, 2015.
“Overview of U.S. Food Law and Regulation” and “Food Safety: Unintended Components/Contaminants of Food,” presentations at Introduction to Food Law and Regulation Conference, Food and Drug Law Institute, February 23, 2015.
2014
“FSMA Update – A Comprehensive Review of FSMA Rules and How to Prepare Your Company for the Long Haul,” panel member and presentation at American Conference Institute program FDA & USDA Compliance Boot Camp, Chicago, September 29, 2014.
“Current and Emerging Regulatory Issues in the Tea and Infusion Products Industry,” presentation at World Tea Expo, Long Beach, CA, May 30, 2014.
2013
“FDA-Related Compliance Issues,” speech at 25th Annual All Hands Meeting, Silicon Valley Association of General Counsel, Santa Clara, CA, December 5, 2013.
“Legal Issues Relating to NSURE and Use of New Technology to Assure Conditions of Safe OTC Use,” speech at American Conference Institute program on OTC Drugs, New York, October 29, 2013.
“Marketing and Advertising – How to Craft the Right Health, Nutrition, Structure-Function, Benefit, and Mental Performance Claims,” speech at American Conference Institute program FDA & USDA Compliance Boot Camp, Chicago, October 1, 2013.
2012
“Inspections: Frequency, Manner and Targeting,” chapter in The Food Safety Modernization Act: A Comprehensive, Practical Guide to the Landmark Legislation, Food and Drug Law Institute, January 2012.
Planning committee member and panel speaker at “Food Safety at the Crossroads: How the Food Safety Modernization Act is Changing the Landscape,” Food and Drug Law Institute, Washington, DC, January 25, 2012.
2011
“Issues in Advertising Law for OTC Drugs and Cosmetics – Ensuring that Claims are Legally Substantiated,” speech at Unilever United States, Inc., Englewood Cliffs, NJ, October 27, 2011.
“Introduction to Medical Device Law,” speech at FDA/CDRH (Food and Drug Law Institute), White Oak, MD, September 7, 2011.
Dwyer, D and A Young, “Regulation of Dietary Supplements,” in Food and Drug Law Institute, A Practical Guide to Food and Drug Law and Regulation (2011).
Dwyer, D and S Ehrlich: “Over-the-Counter Drugs,” in Food and Drug Law Institute, Fundamentals of Law and Regulation (2011)
2010
“FDA Regulatory Briefing – Gelatin,” speech at Rousselot conference, El Paso, TX, April 14, 2010.
Insights
FDA Releases Draft Guidance on Labeling for Plant-Based Milk Alternatives - February 27, 2023
A Masterpiece by Any Other Name: State Hemp Laws - December 11, 2020
California’s Giving Its Cosmetic Laws a Facelift To Go For a More European Look - October 19, 2020
FDA’s Regulations on “Intended Use”: One More Try - September 28, 2020
FDA Issues COVID-19 Policy Providing Temporary Labeling Flexibility to Food Manufacturers - June 5, 2020
CARES Act Will Accelerate OTC Drug Development - April 15, 2020
TTB Finalizes Portions of Modernization of Advertising and Labeling Regulations for Wine, Distilled Spirits, and Malt Beverages Rule - April 7, 2020
New Opportunities for OTC Monograph Drugs under the CARES Act - April 2, 2020
FDA Issues Preventive Controls Final Rule for Human Foods - September 10, 2015